These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mathematical model of influenza A virus production in large-scale microcarrier culture. Möhler L; Flockerzi D; Sann H; Reichl U Biotechnol Bioeng; 2005 Apr; 90(1):46-58. PubMed ID: 15736163 [TBL] [Abstract][Full Text] [Related]
4. Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines. Kalbfuss B; Genzel Y; Wolff M; Zimmermann A; Morenweiser R; Reichl U Biotechnol Bioeng; 2007 May; 97(1):73-85. PubMed ID: 16921531 [TBL] [Abstract][Full Text] [Related]
5. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells. Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028 [TBL] [Abstract][Full Text] [Related]
6. Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses. Opitz L; Salaklang J; Büttner H; Reichl U; Wolff MW Vaccine; 2007 Jan; 25(5):939-47. PubMed ID: 17011087 [TBL] [Abstract][Full Text] [Related]
7. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media. Genzel Y; Olmer RM; Schäfer B; Reichl U Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022 [TBL] [Abstract][Full Text] [Related]
8. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Genzel Y; Fischer M; Reichl U Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544 [TBL] [Abstract][Full Text] [Related]
9. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines. Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387 [TBL] [Abstract][Full Text] [Related]
10. Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium. He C; Yang Z; Tong K J Chromatogr A; 2011 Aug; 1218(31):5279-85. PubMed ID: 21726872 [TBL] [Abstract][Full Text] [Related]
11. Impact of cultivation conditions on N-glycosylation of influenza virus a hemagglutinin produced in MDCK cell culture. Rödig JV; Rapp E; Bohne J; Kampe M; Kaffka H; Bock A; Genzel Y; Reichl U Biotechnol Bioeng; 2013 Jun; 110(6):1691-703. PubMed ID: 23297157 [TBL] [Abstract][Full Text] [Related]
12. Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification. Wickramasinghe SR; Kalbfuss B; Zimmermann A; Thom V; Reichl U Biotechnol Bioeng; 2005 Oct; 92(2):199-208. PubMed ID: 16041807 [TBL] [Abstract][Full Text] [Related]
13. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. Genzel Y; Behrendt I; König S; Sann H; Reichl U Vaccine; 2004 Jun; 22(17-18):2202-8. PubMed ID: 15149778 [TBL] [Abstract][Full Text] [Related]
15. Purification of influenza A virus and preliminary characterization of virus proteins by polyacrylamide gel electrophoresis (PAGE). Chomik M Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):537-40. PubMed ID: 749805 [TBL] [Abstract][Full Text] [Related]
16. Maturation efficiency of viral glycoproteins in the ER impacts the production of influenza A virus. Ueda M; Yamate M; Du A; Daidoji T; Okuno Y; Ikuta K; Nakaya T Virus Res; 2008 Sep; 136(1-2):91-7. PubMed ID: 18550190 [TBL] [Abstract][Full Text] [Related]
17. Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins. Leser GP; Lamb RA Virology; 2005 Nov; 342(2):215-27. PubMed ID: 16249012 [TBL] [Abstract][Full Text] [Related]
18. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668 [TBL] [Abstract][Full Text] [Related]
19. Factors responsible for plaque formation of A/duck/Siberia/272/1998 (H13N6) influenza virus on MDCK cells. Tsuda Y; Isoda N; Sakoda Y; Kida H Virus Res; 2009 Mar; 140(1-2):194-8. PubMed ID: 19146891 [TBL] [Abstract][Full Text] [Related]
20. Impact of adsorbents selection on capture efficiency of cell culture derived human influenza viruses. Opitz L; Lehmann S; Zimmermann A; Reichl U; Wolff MW J Biotechnol; 2007 Sep; 131(3):309-17. PubMed ID: 17765993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]